Mile Bluff Medical Center is nationally recognized for its commitment to providing high-quality diabetes care

The American Heart Association presents the Target: Type 2 Diabetes Participant award for commitment to combating heart disease and stroke in patients with Type 2 diabetes

Mauston, WI, 2024 – Mile Bluff Medical Center has received the American Heart Association’s Target: Type 2 Diabetes℠ Participant award for its commitment to addressing the relationship between diabetes and the risk of heart disease and stroke.

Cardiovascular disease is the leading cause of death and a major cause of heart attacks, strokes and heart failure for people living with Type 2 diabetes – yet in a survey of people age 45 and older with type 2 diabetes conducted by The Harris Poll, only half recognize their risk or have discussed their risk for heart attacks or strokes with their health care providers.[1]

Target: Type 2 Diabetes addresses heart disease and stroke risk factors in patients with Type 2 diabetes as part of the Know Diabetes by Heart™ initiative, by the American Heart Association and American Diabetes Association. Target: Type 2 Diabetes puts the unparalleled expertise of the American Heart Association to work for hospitals nationwide, helping ensure the care provided to patients is aligned with the latest evidence- and research-based guidelines.

“Our participation in Target: Type 2 Diabetes demonstrates our commitment to quality care. We are proud to be a part of the American Heart Association’s® efforts,” said Carmen Liebelt, Mile Bluff Director of Quality and Risk Management.

The Participant award recognizes practices that have completed data submission, including clinical measure entry, and committed to improving quality of care for patients with type 2 diabetes and cardiovascular risk factors.

Each year, program participants apply for award recognition by demonstrating how their organization has committed to providing quality outpatient care for people with Type 2 diabetes. In addition to following treatment guidelines, Target: Type 2 Diabetes participants also empower patients with evidence-based information and tools.

“More than 37 million Americans live with diabetes, and cardiovascular disease is the leading cause of death for people living with Type 2 diabetes,” said Howard Haft, M.D., MMM, CPE, FACPE, American Heart Association volunteer; consultant, senior medical advisor and adjunct professor of medicine at the University of Maryland School of Medicine; and former executive director of the Maryland Primary Care Program with the Maryland Department of Health. “Organizations that participate in programs like this help raise awareness of the link between diabetes and cardiovascular disease and can improve patient outcomes. We are pleased to recognize Mile Bluff Medical Center for its commitment to quality care.”